Puretech Ventures is categorized under Wholesale Pharmaceutical Products in Boston, MA and active since 2006.
Puretech Ventures was established in 2006, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 3254120 by the NAICS.
If you are seeking more information, feel free to contact Thijs Spoor, Chief Executive Officer at the company’s single location by writing to 75 Park Plaza, Boston, Massachusetts MA 02116 or by phoning (617) 482-2333. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Puretech Ventures |
Contact Person: | Thijs Spoor, Chief Executive Officer |
Address: | 75 Park Plaza, Boston, Massachusetts 02116 |
Phone Number: | (617) 482-2333 |
Website Address: | fluoropharma.com |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Wholesale Pharmaceutical Products |
SIC Code: | 5122 |
NAICS Code: | 3254120 |
Share This Business: |
Puretech Ventures was started in 2006 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Thijs Spoor, Chief Executive Officer for inquiries that concern Puretech Ventures by calling the company number (617) 482-2333, as your correspondence is most welcome. Additionally, the physical location of the single location of Puretech Ventures can be found at the coordinates 42.3512,-71.07022 as well as the street address 75 Park Plaza in Boston, Massachusetts 02116.
For its online presence, you may visit Puretech Ventures’s website at fluoropharma.com and engage with its social media outlets through on Twitter and on Facebook.